Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pyxis Oncology (PYXS) Shares Outstanding: 2024-2025

Historic Shares Outstanding for Pyxis Oncology (PYXS) over the last 2 years, with Sep 2025 value amounting to $62.1 million.

  • Pyxis Oncology's Shares Outstanding rose 4.54% to $62.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $62.1 million, marking a year-over-year increase of 4.54%. This contributed to the annual value of $60.0 million for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2025, Pyxis Oncology's Shares Outstanding is $62.1 million, which was up 0.21% from $62.0 million recorded in Q2 2025.
  • Over the past 5 years, Pyxis Oncology's Shares Outstanding peaked at $62.1 million during Q3 2025, and registered a low of $58.8 million during Q1 2024.
  • Its 2-year average for Shares Outstanding is $60.4 million, with a median of $60.0 million in 2024.
  • Data for Pyxis Oncology's Shares Outstanding shows a peak YoY grew of 5.27% (in 2025) over the last 5 years.
  • Quarterly analysis of 2 years shows Pyxis Oncology's Shares Outstanding stood at $60.0 million in 2024, then climbed by 4.54% to $62.1 million in 2025.
  • Its Shares Outstanding stands at $62.1 million for Q3 2025, versus $62.0 million for Q2 2025 and $61.6 million for Q1 2025.